DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Takahashi M, Soejima K, Taniuchi S. et al
Oral immunotherapy combined with omalizumab for high-risk cow’s milk allergy: a randomized controlled trial.
Sci Rep 2017;
7 (01) 17453
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.